Baccus Vascular
This article was originally published in The Gray Sheet
Executive Summary
FDA grants investigational device exemption for Baccus Fino system for deep vein thrombosis, affecting 400,000 people in the U.S. each year. The minimally invasive device is designed to remove blood clots from peripheral veins by enabling rapid disruption and removal of deep vein thrombosis. Clinical trials are slated to begin in June to support 510(k) clearance...